Traditional Chinese medicine and cancer: History, present situation, and development

Cancer treatment with traditional Chinese medicine (TCM) has a long history. Heritage provides general conditions for the innovation and development of TCM in oncology. This article reviews the development of TCM in oncology, interprets the position and function of TCM for cancer prevention and treatment, summarizes the innovations of TCM in oncology over nearly fifty years, and suggests the development direction.

[1]  Yu-Chih Yang,et al.  Herbal Extract of Wedelia chinensis Attenuates Androgen Receptor Activity and Orthotopic Growth of Prostate Cancer in Nude Mice , 2009, Clinical Cancer Research.

[2]  U. Mansmann,et al.  Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. , 2004, Anticancer research.

[3]  A. Adams.  Chinese Herbal Medicines , 2003, Anaesthesia.

[4]  Wei-ru Xu,et al.  Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells , 2011, Medical oncology.

[5]  X. Zhong,et al.  Zoledronic acid exerts antitumor effects in NB4 acute promyelocytic leukemia cells by inducing apoptosis and S phase arrest. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Xin Chen,et al.  Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. , 2005, Blood.

[7]  Yiping Wang,et al.  Chinese herbal medicines for induction of remission in advanced or late gastric cancer. , 2013, The Cochrane database of systematic reviews.

[8]  B. Cassileth,et al.  Integrative oncology: complementary therapies for cancer survivors. , 2008, Hematology/oncology clinics of North America.

[9]  Effects of Traditional Chinese Medicine in Treatment of Breast Cancer Patients After Mastectomy: A Meta-Analysis , 2015, Cell Biochemistry and Biophysics.

[10]  Mingyao Liu,et al.  Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. , 2010, Carcinogenesis.

[11]  M. Saif,et al.  First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer , 2014, Cancer Chemotherapy and Pharmacology.

[12]  Peng Cao,et al.  Identification and Characterization of Anticancer Compounds Targeting Apoptosis and Autophagy from Chinese Native Garcinia Species , 2014, Planta Medica.

[13]  Peng Jiang,et al.  Molecular networks for the study of TCM Pharmacology , 2010, Briefings Bioinform..

[14]  W. Scheithauer,et al.  for treatment of advanced , 1990 .

[15]  J. Sakamoto,et al.  Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis , 2014, Cancer Chemotherapy and Pharmacology.

[16]  Wei-ru Xu,et al.  Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway , 2011, Journal of experimental & clinical cancer research : CR.

[17]  K. Fung,et al.  Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica. , 2013, European journal of medicinal chemistry.

[18]  A. Vickers,et al.  Evaluation of widely consumed botanicals as immunological adjuvants. , 2008, Vaccine.

[19]  D. Charnock-Jones,et al.  The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo , 2011, Angiogenesis.

[20]  X. Hao,et al.  [A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine+cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients]. , 2006, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[21]  Zhe Chen,et al.  The efficacy of traditional Chinese Medicine as an adjunctive therapy in nasopharyngeal carcinoma: a systematic review and meta-analysis. , 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[22]  Fang Liu,et al.  Comparison of Efficacy and Toxicity of Traditional Chinese Medicine (TCM) Herbal Mixture LQ and Conventional Chemotherapy on Lung Cancer Metastasis and Survival in Mouse Models , 2014, PloS one.

[23]  Stephen T. C. Wong,et al.  Computational analysis of image‐based drug profiling predicts synergistic drug combinations: Applications in triple‐negative breast cancer , 2014, Molecular oncology.

[24]  Yan Zhang,et al.  A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia , 2009, Proceedings of the National Academy of Sciences.

[25]  William C S Cho,et al.  The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis. , 2012, Complementary therapies in medicine.

[26]  A. Running,et al.  Integrative Oncology: Managing Cancer Pain with Complementary and Alternative Therapies , 2012, Current Pain and Headache Reports.

[27]  B. Aggarwal,et al.  Curcumin, a component of golden spice: from bedside to bench and back. , 2014, Biotechnology advances.

[28]  Zhen-ye Xu,et al.  Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy , 2011, Journal of Cancer Research and Clinical Oncology.

[29]  T. Efferth,et al.  Artesunate derived from traditional Chinese medicine induces DNA damage and repair. , 2008, Cancer research.

[30]  Yiping Wang,et al.  Chinese herbal medicines for induction of remission in advanced or late gastric cancer. , 2010, The Cochrane database of systematic reviews.

[31]  Mingwei Yu,et al.  The Possibility of Traditional Chinese Medicine as Maintenance Therapy for Advanced Nonsmall Cell Lung Cancer , 2014, Evidence-based complementary and alternative medicine : eCAM.

[32]  Xinna Li,et al.  Silencing SATB1 Inhibits the Malignant Phenotype and Increases Sensitivity of Human Osteosarcoma U2OS Cells to Arsenic Trioxide , 2014, International journal of medical sciences.

[33]  M. Waye,et al.  Photodynamic therapy inhibits p-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a , 2009, Molecular Cancer.

[34]  Yung-chi Cheng,et al.  The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity , 2010, Science Translational Medicine.

[35]  K. Fung,et al.  Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice. , 2014, The Journal of nutritional biochemistry.

[36]  W. Cho,et al.  In vitro and in vivo anti-tumor effects of Astragalus membranaceus. , 2007, Cancer letters.

[37]  K. Fung,et al.  Immunomodulatory Activities of Ganoderma sinense Polysaccharides in Human Immune Cells , 2013, Nutrition and cancer.

[38]  John M Colford,et al.  Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  R. Elashoff,et al.  Patient education integrated with acupuncture for relief of cancer-related fatigue randomized controlled feasibility study , 2011, BMC complementary and alternative medicine.

[40]  D. Haines,et al.  Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways. , 2014, Cancer letters.

[41]  Long Hua,et al.  Shenqifuzheng injection combined with chemotherapy in the treatment of advanced gastric cancer: a systematic review and meta-analysis. , 2014, Journal of cancer research and therapeutics.

[42]  Lei Li,et al.  Establishing Chinese medicine characteristic tumor response evaluation system is the key to promote internationalization of Chinese medicine oncology , 2012, Chinese Journal of Integrative Medicine.

[43]  Xiao-bing Yang,et al.  Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study. , 2014, Complementary therapies in medicine.

[44]  Jian-Hua Tong,et al.  Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML , 2010, Science.

[45]  Y. Tong,et al.  The Efficacy of Chinese Herbal Medicine as an Adjunctive Therapy for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis , 2013, PloS one.

[46]  K. Fung,et al.  Eriocalyxin B-induced apoptosis in pancreatic adenocarcinoma cells through thiol-containing antioxidant systems and downstream signalling pathways. , 2014, Current molecular medicine.